Trials / Completed
CompletedNCT02424318
Topiramate and Cerebrovascular Response in Migraineurs
Effect of Topiramate on Cerebrovascular Response to Photic Stimulation in Migraineurs
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- SMG-SNU Boramae Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effect of topiramate on cerebrovascular reactivity and mean flow velocity to photic stimulation in migraineurs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topiramate | topiramate 25mg twice 1 week -\> topiramate 50mg twice 7 weeks |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-12-01
- Completion
- 2010-12-01
- First posted
- 2015-04-23
- Last updated
- 2015-04-23
Source: ClinicalTrials.gov record NCT02424318. Inclusion in this directory is not an endorsement.